FDA panel: Painkiller plan not strong enough
FDA advisory panel members overwhelmingly rejected a plan to reduce the misuse and abuse of long-acting painkillers like OxyContin, saying they did not think it was strong enough to control the use of such prescription narcotics. Report
Original Source of FDA panel: Painkiller plan not strong enough
